About Regions Cancer Care Center
Clinical Trials at Regions Cancer Care Center
During the past decade, Regions Cancer Care Center conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 2 clinical trials were completed, i.e. on
average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 2 clinical trials were completed. i.e. 28.6%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Regions Cancer Care Center" #1 sponsor was "Pfizer" with 3 trials, followed by "Calithera Biosciences, Inc" with 1 trials
sponsored, "Chinook Therapeutics, Inc. (formerly Aduro)" with 1 trials sponsored, "Dragonfly Therapeutics" with 1 trials sponsored and "GlycoNex, Inc."
with 1 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Regions Cancer Care Center"
#1 collaborator was "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "Pierre Fabre Laboratories" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Regions Cancer Care Center
According to Clinical.Site data, the most researched conditions in "Regions Cancer Care Center" are
"Advanced Solid Tumors" (2 trials), "Solid Tumors" (2 trials), "Advanced Cancer" (1 trials), "Advanced Solid Tumor" (1 trials) and "Anemia, Refractory, With Excess of Blasts" (1 trials). Many other conditions were trialed in "Regions Cancer Care Center" in a lesser frequency.
Clinical Trials Intervention Types at Regions Cancer Care Center
Most popular intervention types in "Regions Cancer Care Center" are "Drug" (10 trials). Other intervention types were less common.
The name of intervention was led by "ADU-S100" (1 trials), "ARRY-382" (1 trials), "Binimetinib" (1 trials), "DF6002" (1 trials) and "GNX102" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Regions Cancer Care Center
The vast majority of trials in "Regions Cancer Care Center" are
10 trials for "All" genders.
Clinical Trials Status at Regions Cancer Care Center
Currently, there are NaN active trials in "Regions Cancer Care Center".
undefined are not yet recruiting,
3 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Regions Cancer Care Center,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Regions Cancer Care Center, 8 "Phase 1"
clinical trials were conducted, 7 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".